Immunomonitoring in glioma immunotherapy: current status and future perspectives.
about
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.Immunotherapy in glioblastoma: emerging options in precision medicineA comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.
P2860
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
@en
type
label
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
@en
prefLabel
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
@en
P2093
P2860
P1476
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
@en
P2093
Andrew T Parsa
Daniel E Oyon
Jonathan B Lamano
Joseph D DiDomenico
Kartik Kesavabhotla
Leonel Ampie
Orin Bloch
Winward Choy
P2860
P2888
P356
10.1007/S11060-015-2018-4
P577
2015-12-05T00:00:00Z
P6179
1022172753